首页> 外国专利> THIENO2,3-DPYRIMIDIN-4(3H)-ONE, ISOXAZOLO5,4-DPYRIMIDIN-4(5H)-ONE AND ISOTHIAZOLO5,4-DPYRIMIDIN-4(5H)-ONE DERIVATIVES AS CALCIUM RECEPTOR ANTAGONISTS

THIENO2,3-DPYRIMIDIN-4(3H)-ONE, ISOXAZOLO5,4-DPYRIMIDIN-4(5H)-ONE AND ISOTHIAZOLO5,4-DPYRIMIDIN-4(5H)-ONE DERIVATIVES AS CALCIUM RECEPTOR ANTAGONISTS

机译:THIENO [2,3-D] PYRIMIDIN-4(3H)-one,ISOXAZOLO [5,4-D] PYRIMIDIN-4(5H)-one和ISOTHIAZOLO [5,4-D] PYRIMIDIN-4(5H)-1衍生物作为钙受体拮抗剂

摘要

The present invention is directed to novel thieno[2,3-d]pyrimidin-4(3H)-one, isoxazolo[5,4-d]pyrimidin-4(5H)-one and isothiazolo[5,4-d]pyrimidin-4(5H)-one derivatives and pharmaceutically acceptable salts thereof of structural formula (I), wherein the variables R1, R2, R3, X and Z are as described herein. Also provided are pharmaceutical compositions comprising the compounds of formula I as well as methods of treatment employing compounds of formula I to treat a disease or disorder characterized by abnormal bone or mineral homeostasis such as hypoparathyroidism, osteoporosis, osteopenia, periodontal disease, Paget's disease, bone fracture, osteoarthritis, rheumatoid arthritis, and humoral hypercalcemia of malignancy.
机译:本发明涉及新颖的噻吩并[2,3-d]嘧啶-4(3H)-one,异恶唑并[5,4-d]嘧啶-4(5H)-one和异噻唑并[5,4-d]嘧啶结构式(I)的-4(5H)-1衍生物及其药学上可接受的盐,其中变量R1,R2,R3,X和Z如本文所述。还提供了包含式I化合物的药物组合物,以及使用式I化合物治疗以骨或矿物质稳态异常为特征的疾病或失调的治疗方法,例如甲状旁腺功能低下,骨质疏松,骨质减少,牙周病,佩吉特氏病,骨骨折,骨关节炎,类风湿关节炎和恶性体液高钙血症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号